Healthcare Innovation Partners is a Venture Capital impact fund partnering with biotechnology, medical device, and diagnostic companies in the US and Canada. We invest primarily in the Oncology and Cardiovascular sectors, with the remaining allocations to opportunistic investing in other heath care sectors with a keen eye on metabolic, neurodegenerative and longevity. HIP invests in therapeutics, diagnostics, and devices focusing primarily on IND through Phase 1 assets on the drug regulatory pathway and verification & validation and clinical stage assets in devices. We invest with the social mission of improving heath care access & delivery as well as donating 10% of our fund carry to support non-profits research organizations in oncology and cardiovascular. Our team is composed of clinicians, researchers, pharmaceutical executives, and venture capitalists who have successfully built and invested a multitude of life science companies.